DIABETES DRUG
MAY THREATEN VISION
Patients taking glitazones, a new class of drug that specifically targets insulin resistance, should be careful to note that they may be at increased risk for diabetic macular edema (DME), a vision-threatening complication. According to recent research involving diabetic patients with DME, those taking glitazones, including pioglitazone and rosiglitazone, were 2.6 times more likely to develop DMA than those not taking the drugs. Thus, diabetics taking any one of this class of drugs are strongly advised to inform their ophthalmologists that they are doing so. Diabetic macular edema is characterized by swelling in the central portion of the retina due to leaking of fluid from blood vessels. Blurring in the middle (and periphery) of the visual field results.
This column about specific drugs for diabetics has been brought to you in the interest of better eye heath. At LOTUS EYECARE, we stress preventive health care for the entire family. When is the last time you or any of your family members had a thorough eye examination? We’re located at 3303 S. Halsted, Suite 200, where we will discuss all the available options with you. We’re currently accepting new patients and welcome you to call 773.376.2020 to schedule an appointment. We provide professional and personalized eye care for the entire family.
P.S. Diabetic macular edema is divided into two types, focal and diffuse, each of which responds to a different type of laser treatment.
Dedicated to the health of your eyes.
Archive of columns
|
